$137 million
Fri December 7th, 2018
115th Congress
Sponsor: Sen. John Isakson — R — GA
A bill to amend the Federal Food, Drug, and Cosmetic Act to clarify the regulatory framework with respect to certain nonprescription drugs that are marketed without an approved new drug application, and for other purposes.
Don't be sad- we've got your back. Just enter your email below and instructions on resetting your password will be sent to you.
×